The following is a round-up of updates by London-listed companies, issued on Monday and Tuesday and not separately reported by Alliance News:
Faron Pharmaceuticals Oy - Finland-based.
Kodal Minerals up on amended Bougouni agreement proactiveinvestors.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.co.uk Daily Mail and Mail on Sunday newspapers.
On March 29, Kanglongda announced that it jointly signed an "Agreement to Terminate the Binding Terms Sheet Regarding the Purchase of Spodumene from the Bougouni Lithium Project" with Kodal Minerals PLC (referred to as "KODAL"), Hainan Mining and its controlling subsidiary, Kodal Mining UK (referred to as "KMUK"). According to the agreement, KMUK will pay Suay Chin a total of 14 million US dollars in termination fees in two installments. After receiving the first installment of 7 million US dollars, the "Bougouni (Bougouni) Mine Project Spodumene Sales Binding Term Memorandum" signed by Suay Chin and KODAL in 2017 will terminate, meaning Suay Chin will give up the priority right to underwrite no less than 80% of the concentrate products for the first three years after the Bougouni carp mine project starts production; KMUK needs to complete the payment of all termination fees before the first batch of spodumene is shipped from Mali or before Octob
Kodal enters into agreement to terminate Suay Chin right of first refusal miningweekly.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miningweekly.com Daily Mail and Mail on Sunday newspapers.